Life-extending therapies, engineered with scientific precision.
OncoVantaHealth is a high-performance command center for targeted oncology treatments - vetted, transparent, and delivered with clinical authority.
- 5
- Targeted Therapies
- 100%
- Rx Verified
- 24/7
- Clinical Support
Dr. Marcus Hale, PharmD
Lead Oncology Pharmacist - 24/7 Rx Line
Rx Verified
Every order reviewed by licensed pharmacists
Clinically Vetted
Targeted therapies backed by trial data
Cold-Chain Delivery
Temperature-controlled, trackable shipping
In partnership with leading cancer institutes
Our pharmacy operates in affiliation with world-class cancer research and treatment centres - ensuring every therapy we dispense meets the highest clinical standards across North America.
Princess Margaret Cancer Centre
University Health Network - Toronto, ON
MedStar Georgetown Cancer Institute
MedStar Georgetown University Hospital - Washington, DC
A pharmacy built around precision oncology
OncoVantaHealth is not a general pharmacy. Our entire workflow is engineered for the realities of modern cancer treatment.
OncoVantaHealth operates as a specialized oncology pharmacy focused exclusively on targeted and precision cancer therapies. Unlike general pharmacies, our clinical workflow is built around the realities of modern oncology care: molecularly targeted agents, oral tyrosine kinase inhibitors, hormone receptor modulators, and adjunctive treatments that require careful handling, precise dosing, and ongoing clinical oversight. Every therapy in our formulary is selected against published efficacy data, regulatory approvals, and consensus oncology guidelines.
Our pharmacists review each prescription for indication appropriateness, dosing accuracy, drug-drug interactions, and patient-specific risk factors such as hepatic and renal function. This clinical-first model means that what reaches the patient is not simply a dispensed product, but a therapy that has been individually verified against the latest evidence and the patient's complete treatment context - because in oncology, the difference between a correct regimen and a near-correct one can be measured in outcomes.
Evidence-based
Therapies selected against published clinical data
Indication-verified
Every Rx checked against the approved use
Risk-aware
Dosing adjusted to hepatic & renal profile
From prescription to patient, verified at every step
A clear, clinical pathway ensures each therapy is prescribed, verified, dispensed, and delivered without unnecessary delay - and with full traceability.
- 01
Prescription intake
Prescribers or patients submit a valid oncology prescription through our secure intake. Our team verifies prescriber credentials and prescription completeness within one business day.
- 02
Clinical verification
A licensed oncology pharmacist reviews the therapy for indication, dosing, interactions, and contraindications. Where needed, we coordinate directly with the treating oncologist to clarify or adjust the regimen.
- 03
Access & coverage
Our access team works with payers, manufacturers, and patient-assistance programs to reduce financial barriers and confirm coverage before dispensing.
- 04
Cold-chain dispensing
Verified therapies are packaged in temperature-controlled containers with continuous monitoring, preserving stability from our pharmacy to the patient's door.
- 05
Delivery & tracking
Shipments are fully trackable across the United States and Canada, with signature handling and cold-chain confirmation on arrival.
- 06
Ongoing support
After delivery, patients receive counseling, adherence check-ins, and a direct line to our clinical team for questions or side-effect management.
The therapeutic categories we dispense
Our formulary spans the major categories of modern targeted oncology. Each category is curated with input from oncology specialists and updated as new agents receive regulatory approval, so prescribers and patients are always working from the current standard of care.
Tyrosine kinase inhibitors
TKIs target specific mutations driving tumor growth, offering oral alternatives to traditional infusion therapy for selected malignancies.
Hormone receptor therapies
These agents address hormone-sensitive cancers such as certain breast and prostate malignancies, modulating the pathways that fuel tumor progression.
Angiogenesis inhibitors
By disrupting the blood supply that tumors rely on to grow and spread, these therapies restrict the resources a tumor can draw on.
Adjunctive & supportive therapies
Supportive treatments manage side effects, preserve quality of life, and help patients remain on their prescribed regimens at full dose.
Product pages include mechanism of action, target protein, clinical indication, and dosing information so prescribers and patients can make informed decisions grounded in the underlying science rather than marketing claims.
Non-negotiable standards in oncology dispensing
Temperature-sensitive therapies stay within validated cold-chain ranges from receipt through final delivery.
Quality and safety are non-negotiable in oncology dispensing. OncoVantaHealth maintains rigorous protocols across every stage of the pharmacy workflow. Our facility follows cold-chain standards that keep temperature-sensitive therapies within validated ranges from receipt through final delivery. Each prescription undergoes a multi-point clinical check covering indication, dose, route, frequency, interactions, and patient-specific contraindications.
We maintain complete audit trails for every order, from intake through fulfillment, supporting both regulatory compliance and patient safety reviews. Our pharmacists stay current with evolving oncology evidence, drug approvals, and safety communications, and we proactively contact prescribers and patients when new information affects an active therapy. This continuous, evidence-driven oversight is what separates a specialized oncology pharmacy from a conventional dispenser - and what gives patients and prescribers confidence in every shipment.
Built for patients and the oncologists who treat them
For patients
One-on-one counseling, clear instructions, adherence support, and a 24/7 clinical line for urgent questions. We help you understand your regimen, what to expect, and when to reach out - so therapy feels less like a black box and more like a partnership.
For prescribers
A responsive partner for prescription verification, prior authorization coordination, and therapy adjustments based on real-world response. We also help navigate manufacturer patient-assistance programs and financial support options, because cost should not be a barrier to life-extending care.
Whether you are a patient beginning a new regimen or an oncologist coordinating complex care, our clinical team is available to support every step - from the first prescription through long-term adherence and outcome monitoring.
Why a specialized oncology pharmacy matters
Cancer therapy is not like other prescriptions. Targeted oncology drugs often have narrow therapeutic windows, complex interaction profiles, and storage requirements that a conventional pharmacy is not equipped to manage. A missed dose, a wrong-time dose, or an unrefrigerated shipment can compromise months of treatment. That is why specialization matters - and why it is the foundation of how we operate.
At OncoVantaHealth, oncology is not one of many services we offer - it is the only service we offer. Our pharmacists train specifically in oncology therapeutics, our supply chain is built around cold-chain integrity, and our clinical protocols are designed for the complexity of cancer regimens rather than adapted from general pharmacy workflows.
For patients, this means fewer errors, better adherence support, and a care team that understands the science behind the therapy. For prescribers, it means a dispensing partner who can engage at a clinical level - flagging interactions, confirming dosing, and coordinating adjustments - rather than simply filling a script. In oncology, that depth of partnership is not a luxury; it is a safety requirement.
Oncology medicine information you can trust
Finding reliable oncology drug information and cancer medicine information can be difficult. OncoVantaHealth provides clear, scientifically grounded resources across the full range of oncology treatment options - from targeted cancer therapy to established cancer therapy medications - so patients and prescribers can make informed decisions.
Whether you are researching oncology pharmaceutical products for a specific diagnosis or comparing oncology medicines online information, our catalog and clinical summaries are built to support your decisions. We organize cancer treatment medications by mechanism, indication, and target protein, and every product page pairs prescribing data with plain-language context. For patients navigating access across North America, we also detail prescription cancer medicines Canada-wide, with Rx-verified fulfillment and cold-chain delivery to every province.
Oncology medicines Canada
A formulary curated for Canadian patients, with provincial delivery and Rx verification.
Cancer drug information Canada
Indication, dosing, interaction, and safety profiles for each therapy we dispense.
Cancer treatment resources Canada
Clinical summaries and adherence support for patients and treating oncologists.
Oncology treatment options
Targeted, hormone, and supportive therapies organized by cancer category.
Spotlight: daraxonrasib (RMC-6236) and KRAS G12D research
We track investigational therapies so our formulary and clinical guidance stay ahead of the science.
RMC-6236 - known as daraxonrasib - is an investigational daraxonrasib KRAS G12D inhibitor under active oncology research for KRAS G12D-mutant solid tumors. As daraxonrasib clinical trials advance across early- and late-stage programs, our clinical team monitors RMC-6236 information and the broader RMC-6236 oncology research landscape to keep patients and prescribers informed about emerging oncology treatment options.
Daraxonrasib pancreatic cancer research is of particular interest, given the limited targeted options available for KRAS G12D-mutant pancreatic tumors. We do not dispense investigational therapies, but we follow daraxonrasib pancreatic cancer research closely so that when an approved targeted cancer therapy becomes available, our pharmacy is ready to support verification, access, and cold-chain delivery across the USA and Canada.
Investigational therapies referenced here are not available for dispensing. This information is provided for educational purposes and to help patients and prescribers understand the research pipeline. Speak with your treating oncologist about clinical trial eligibility.
Pancreatic cancer treatment and RAS-targeted therapy
Pancreatic cancer remains one of the most challenging cancers to treat, and access to clear cancer treatment information Canada-wide is essential for patients and prescribers alike.
OncoVantaHealth provides oncology medicine information across the full spectrum of pancreatic cancer medication - from established prescription oncology medicine to emerging RAS inhibitor cancer treatment options. For patients with metastatic pancreatic cancer treatment needs or pancreatic adenocarcinoma treatment planning, our clinical summaries cover mechanism, indication, dosing, and safety for each therapy we track.
Among the therapies we follow is daraxonrasib - also referenced under the research code RASONQUE - a RAS-targeted investigational agent of growing interest in daraxonrasib cancer treatment research. While daraxonrasib Canada availability and RASONQUE Canada access depend on regulatory approval and ongoing clinical trials, we monitor this pipeline closely so our team is prepared to support patients the moment an approved pancreatic cancer treatment becomes dispensable.
Investigational agents such as daraxonrasib (RASONQUE) are not available for dispensing. This content supports awareness of the research pipeline. Speak with your treating oncologist about approved pancreatic cancer treatment options and clinical trial eligibility.
Trusted clinical & regulatory resources
We encourage patients and prescribers to consult authoritative external sources for independent oncology information, clinical trial listings, and regulatory guidance.
U.S. Food & Drug Administration
>Drug approval, labeling, and safety information for prescription oncology therapies.
Health Canada
>Regulatory guidance and drug product database for Canadian patients and prescribers.
ClinicalTrials.gov
>Searchable registry of clinical trials, including daraxonrasib and RAS-targeted research.
National Cancer Institute
>Comprehensive cancer treatment information, research, and statistics.
American Cancer Society
>Patient-facing guidance on cancer treatment, medications, and support.
World Health Organization - Cancer
>Global oncology public health data and treatment guidance.
How OncoVantaHealth fits into your care
The most frequent questions from patients and prescribers, answered plainly. For more, visit our full FAQ.
Do you replace my oncologist?
No. Your oncologist determines the therapy; we ensure it is dispensed correctly, delivered safely, and supported throughout treatment. We complement the treating oncologist, not replace them.
How quickly do therapies ship?
Once a prescription is verified and coverage is confirmed, most therapies ship within one to two business days, with cold-chain delivery across the United States and Canada.
What about cost and coverage?
Because oncology therapies can be expensive, our access team works proactively with insurers and manufacturer assistance programs to identify every available avenue for financial support.
What happens after delivery?
The relationship does not end at the doorstep. Our clinical team remains available for questions, side-effect guidance, and adherence support throughout the course of therapy, because continuity of care is as important as the therapy itself.
The Therapy Matrix
Speak with our clinical team.
Our pharmacists and oncology specialists are available around the clock to guide therapy selection, dosing, and access.
Contact Support